2023
The Promise of Pre-Exposure Prophylaxis – Examining Awareness, Knowledge, and Willingness to use Different Modalities Among US-Based African Immigrants
Aidoo-Frimpong G, Agbemenu K, Adzrago D, Akyirem S, Boateng S, Nelson L. The Promise of Pre-Exposure Prophylaxis – Examining Awareness, Knowledge, and Willingness to use Different Modalities Among US-Based African Immigrants. Journal Of Immigrant And Minority Health 2023, 25: 1331-1338. PMID: 37378713, DOI: 10.1007/s10903-023-01515-z.Peer-Reviewed Original ResearchConceptsPrEP awarenessInjectable PrEPPrEP modalitiesExact testHIV preexposure prophylaxisPre-exposure prophylaxisChi-squaredFisher's exact testEffective prevention toolPearson chi-squaredPrEP outcomesPreexposure prophylaxisHIV infectionOral pillsHIV preventionSociodemographic factorsHealthcare providersSociodemographic characteristicsPrEPEducational statusPrevention toolAfrican immigrantsProphylaxisModalitiesResearch evidence
2019
Treatment of locally advanced or metastatic urothelial carcinoma: Analysis of expert and community healthcare provider practice trends.
Rosenthal K, Galsky M, Milowsky M, Petrylak D, Rosenberg J, Obholz K, Plimack E. Treatment of locally advanced or metastatic urothelial carcinoma: Analysis of expert and community healthcare provider practice trends. Journal Of Clinical Oncology 2019, 37: 389-389. DOI: 10.1200/jco.2019.37.7_suppl.389.Peer-Reviewed Original ResearchImmune checkpoint inhibitorsCisplatin-based chemotherapyMetastatic urothelial carcinomaUrothelial carcinomaHealthcare providersExact testDifferent immune checkpoint inhibitorsPD-L1 testingFischer's exact testFDA label changePearson chi-squaredEligible ptsCheckpoint inhibitorsEligible casesTreatment indicationsTreatment decisionsClinical practicePractice trendsNew indicationsExpert recommendationsChi-squaredCarcinomaLabel changes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply